AsparaginaseHypersensitivityDrug HypersensitivityAntineoplastic Combined Chemotherapy ProtocolsAnaphylaxisPrecursor Cell Lymphoblastic Leukemia-LymphomaAsparagineErwiniaChemotherapy, AdjuvantFood HypersensitivityPassive Cutaneous AnaphylaxisAspartate-Ammonia LigaseImmunoglobulin EAntineoplastic AgentsAllergensDimethyldithiocarbamateAnti-Allergic AgentsSkin TestsTreatment OutcomeHypersensitivity, ImmediateDesensitization, ImmunologicDoxorubicinDrug Administration ScheduleHistamine ReleaseCombined Modality TherapyInsect Bites and StingsLeukemia L5178CisplatinAnisakisPeanut HypersensitivityMethotrexateEgg HypersensitivityMast CellsCyclophosphamideCytarabinePatch TestsForssman AntigenLactate dehydrogenase-elevating virusAntigens, PlantReceptors, IgEArachis hypogaeaPolyethylene GlycolsNut HypersensitivityBasophilsGlutamineMilk HypersensitivitySurvival AnalysisNeoadjuvant TherapyDrug Eruptions2S Albumins, PlantGlutaminasePrognosisInjections, IntramuscularArthus ReactionDisease-Free SurvivalEtoposideBreast NeoplasmsDermatitis, Allergic ContactAspartate Ammonia-LyaseNeoplasm StagingPaclitaxelUrticariaDaunorubicin6-MercaptopurineVulvar VestibulitisRecurrenceSurvival RateBasophil Degranulation TestLung NeoplasmsAspartic AcidBetulaRemission InductionLatex HypersensitivityBee VenomsDrug MonitoringCell Degranulation